M
Mai Peptide
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C | 8 | 7.0 | 4.7 | 10.0 | 17 Dec 2025 |
| Ipamorelin | C | 6 | 8.1 | 4.8 | 9.9 | 21 Aug 2025 |
| Retatrutide | E | 25 | 8.0 | 2.2 | 10.0 | 4 Nov 2025 |
| Tirzepatide | E | 16 | 7.0 | 2.0 | 10.0 | 25 Nov 2025 |
| 5-amino-1MQ | C | 2 | 5.9 | 4.1 | 7.8 | 24 May 2026 |
| AHK-CU | C | 4 | 7.7 | 4.9 | 10.0 | 24 May 2026 |
| Andarine S4 | C | 2 | 6.3 | 5.3 | 7.3 | 21 May 2026 |
| Arimidex (Anastrozole) | X | 1 | 5.5 | 5.5 | 5.5 | 9 Jun 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | C | 5 | 7.6 | 4.6 | 10.0 | 21 May 2026 |
| BMK ethyl glycidate CAS 41232-97-7 | C | 2 | 8.8 | 7.7 | 10.0 | 23 May 2026 |
| BPC157 5mg + TB500 5mg Blend | C | 2 | 7.2 | 6.5 | 8.0 | 19 Jan 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | C | 3 | 8.5 | 7.5 | 9.5 | 21 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | C | 3 | 4.9 | 3.6 | 6.2 | 19 Jan 2026 |
| DHB (1-Test Cyp) | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| Dianabol | C | 4 | 7.5 | 6.1 | 8.7 | 23 May 2026 |
| Drostanolone Propionate (Mast P) Raw | C | 5 | 7.7 | 5.6 | 9.5 | 19 Jan 2026 |
| DSIP | C | 2 | 8.1 | 7.2 | 8.9 | 20 May 2026 |
| Dutasteride | C | 4 | 8.1 | 7.4 | 9.5 | 21 May 2026 |
| EPO | C | 3 | 7.6 | 5.9 | 8.6 | 19 Jan 2026 |
| Halotestin (Fluoxymesterone) | X | 1 | 7.8 | 7.8 | 7.8 | 7 May 2025 |
| HMG | C | 5 | 7.9 | 6.6 | 8.5 | 25 May 2026 |
| LGD-4033 (Ligandrol) | C | 2 | 7.3 | 6.6 | 8.1 | 21 May 2026 |
| Livagen | C | 3 | 8.5 | 6.6 | 10.0 | 25 May 2026 |
| Methylene Blue | C | 5 | 7.2 | 4.9 | 10.0 | 24 May 2026 |
| Ostarine (MK-2866) | C | 4 | 7.2 | 6.4 | 8.6 | 23 May 2026 |
| PE 22-28 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jul 2025 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | C | 5 | 7.4 | 5.9 | 8.9 | 19 Jan 2026 |
| Primobolan Oral (Methenolone Acetate) | C | 4 | 6.7 | 5.1 | 8.5 | 23 May 2026 |
| Propionyl chloride CAS 79-03-8 | X | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X | 1 | 7.4 | 7.4 | 7.4 | 8 Jul 2025 |
| Sildenafil Raw | C | 5 | 7.8 | 6.8 | 10.0 | 20 May 2026 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | C | 2 | 8.3 | 7.9 | 8.7 | 24 May 2026 |
| SNAP-8 | C | 5 | 8.4 | 6.7 | 10.0 | 26 Jan 2026 |
| SR9009 | C | 2 | 7.8 | 5.7 | 10.0 | 21 May 2026 |
| Telmisartan | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jun 2025 |
| Test Undecanoate | C | 2 | 7.7 | 7.5 | 7.9 | 24 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Halotestin (Fluoxymesterone) | 5.1 | 25mg | 21.4mg | -14.5% | 96.27% | Lab B |
| 25 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.9 | 10g | 10.5g | +5.0% | 95.31% | Lab C |
| 24 May 2026 | Dutasteride | 5.0 | 50mg | 51.1mg | +2.2% | 95.81% | Lab E |
| 24 May 2026 | EPO | 5.3 | 15mg | 17.0mg | +13.2% | 96.68% | Lab E |
| 24 May 2026 | Tirzepatide | 5.7 | 30mg | 25.3mg | -15.7% | 99.06% | Lab E |
| 24 May 2026 | Dutasteride | 6.1 | 25mg | 25.3mg | +1.3% | 99.70% | Lab A |
| 24 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 6.8 | 100g | 91.5g | -8.5% | 97.19% | Lab F |
| 24 May 2026 | Sildenafil Raw | 9.6 | 500g | 524.1g | +4.8% | 99.79% | Lab D |
| 24 May 2026 | LGD-4033 (Ligandrol) | 5.8 | 20mg | 23.0mg | +14.9% | 97.99% | Lab G |
| 24 May 2026 | Ostarine (MK-2866) | 9.3 | 20mg | 20.4mg | +2.0% | 98.34% | Lab F |
| 24 May 2026 | DSIP | 6.2 | 20mg | 25.0mg | +24.8% | 98.28% | Lab D |
| 24 May 2026 | Methylene Blue | 8.7 | 50mg | 47.3mg | -5.5% | 98.97% | Lab G |
| 24 May 2026 | Ostarine (MK-2866) | 7.4 | 100mg | 88.1mg | -11.9% | 98.07% | Lab G |
| 23 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.6 | 200mg/ml | 235.3mg/ml | +17.7% | 97.09% | Lab B |
| 23 May 2026 | HMG | 6.0 | 50mg | 46.9mg | -6.1% | 96.02% | Lab F |
| 23 May 2026 | Livagen | 7.7 | 30mg | 31.1mg | +3.6% | 99.48% | Lab B |
| 23 May 2026 | SNAP-8 | 6.2 | 2mg | 2.4mg | +21.3% | 97.99% | Lab F |
| 23 May 2026 | Sildenafil Raw | 4.9 | 100g | 103.2g | +3.2% | 97.02% | Lab E |
| 22 May 2026 | GHK-Cu | 5.8 | 100mg | 86mg | -14.0% | 99.90% | Lab E |
| 22 May 2026 | Retatrutide | 8.0 | 40mg | 40.1mg | +0.3% | 99.90% | Lab E |
| 21 May 2026 | Ipamorelin | 9.9 | 5mg | 5.26mg | +5.2% | 99.90% | Lab E |
| 21 May 2026 | Ipamorelin | 7.8 | 10mg | 10.3mg | +3.0% | 99.81% | Lab E |
| 21 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.0 | 2mg | 2.2mg | +8.3% | 99.34% | Lab C |
| 21 May 2026 | Propionyl chloride CAS 79-03-8 | 7.3 | 10g | 10.9g | +9.3% | 96.57% | Lab B |
| 21 May 2026 | Sildenafil Raw | 7.0 | 500g | 593.7g | +18.7% | 99.01% | Lab F |
| 21 May 2026 | Retatrutide | 8.4 | 20mg | 21.8mg | +9.0% | 99.75% | Lab E |
| 21 May 2026 | Tirzepatide | 7.9 | 30mg | 31.5mg | +5.0% | 98.92% | Lab E |
| 21 May 2026 | DHB (1-Test Cyp) | 8.6 | 200mg/ml | 229.4mg/ml | +14.7% | 98.80% | Lab A |
| 21 May 2026 | Drostanolone Propionate (Mast P) Raw | 8.9 | 5g | 6.1g | +22.1% | 97.03% | Lab E |
| 21 May 2026 | Livagen | 8.6 | 30mg | 31.0mg | +3.2% | 96.87% | Lab C |
| 21 May 2026 | SNAP-8 | 8.6 | 5mg | 5.9mg | +18.6% | 98.04% | Lab A |
| 20 May 2026 | Ostarine (MK-2866) | 6.5 | 10mg | 12.3mg | +23.2% | 97.23% | Lab C |
| 19 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 8.2 | 10g | 11.4g | +13.9% | 95.82% | Lab G |
| 19 May 2026 | Dianabol | 7.9 | 50mg | 48.5mg | -3.0% | 96.55% | Lab A |
| 19 May 2026 | Dutasteride | 9.2 | 25mg | 26.0mg | +3.9% | 98.29% | Lab G |
| 19 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 8.1 | 5g | 5.2g | +3.2% | 95.21% | Lab B |
| 19 May 2026 | Primobolan Oral (Methenolone Acetate) | 7.9 | 20mg | 22.0mg | +10.2% | 97.61% | Lab C |
| 19 May 2026 | Sildenafil Raw | 7.3 | 500g | 457.0g | -8.6% | 97.56% | Lab C |
| 17 May 2026 | Andarine S4 | 7.2 | 25mg | 24.0mg | -4.0% | 98.61% | Lab F |
| 17 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.7 | 300mg/ml | 359.3mg/ml | +19.8% | 95.45% | Lab C |
| 17 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 10.0 | 10mg | 10.6mg | +5.7% | 97.65% | Lab C |
| 17 May 2026 | Drostanolone Propionate (Mast P) Raw | 9.7 | 100g | 94.2g | -5.8% | 97.99% | Lab G |
| 17 May 2026 | Drostanolone Propionate (Mast P) Raw | 5.5 | 100g | 111.1g | +11.1% | 97.80% | Lab G |
| 17 May 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 7.2 | 100mg/ml | 91.8mg/ml | -8.2% | 96.65% | Lab G |
| 17 May 2026 | Sildenafil Raw | 7.4 | 1g | 1.0g | +1.4% | 97.33% | Lab B |
| 29 Jan 2026 | AHK-CU | 7.5 | 2mg | 1.7mg | -14.6% | 99.77% | Lab C |
| 29 Jan 2026 | Dianabol | 7.2 | 100mg | 118.9mg | +18.9% | 95.55% | Lab F |
| 29 Jan 2026 | LGD-4033 (Ligandrol) | 10.0 | 50mg | 45.7mg | -8.7% | 96.84% | Lab A |
| 29 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.5 | 10g | 11.2g | +12.3% | 99.86% | Lab G |
| 26 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 8.8 | 100mg/ml | 124.9mg/ml | +24.9% | 99.07% | Lab B |
| 19 Jan 2026 | AHK-CU | 6.9 | 50mg | 49.9mg | -0.3% | 98.71% | Lab D |
| 19 Jan 2026 | Dutasteride | 7.9 | 50mg | 49.0mg | -2.1% | 95.72% | Lab C |
| 19 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 5.7 | 1g | 0.9g | -7.3% | 96.35% | Lab E |
| 9 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 6.0 | 30mg | 28.3mg | -5.8% | 95.88% | Lab C |
| 9 Jan 2026 | EPO | 6.6 | 10mg | 9.1mg | -9.5% | 96.45% | Lab B |
| 9 Jan 2026 | SR9009 | 8.1 | 100mg | 115.3mg | +15.3% | 99.89% | Lab B |
| 7 Jan 2026 | 5-amino-1MQ | 8.0 | 15mg | 18.5mg | +23.4% | 95.96% | Lab E |
| 7 Jan 2026 | Arimidex (Anastrozole) | 6.7 | 100mg | 121.9mg | +21.9% | 99.17% | Lab B |
| 7 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.0 | 50mg | 59.4mg | +18.8% | 95.33% | Lab C |
| 7 Jan 2026 | Drostanolone Propionate (Mast P) Raw | 8.8 | 5g | 4.3g | -13.5% | 98.06% | Lab E |
| 7 Jan 2026 | HMG | 8.5 | 30mg | 36.4mg | +21.3% | 99.49% | Lab C |
| 7 Jan 2026 | Ostarine (MK-2866) | 6.7 | 25mg | 22.7mg | -9.1% | 99.30% | Lab E |
| 7 Jan 2026 | SNAP-8 | 8.2 | 50mg | 59.8mg | +19.7% | 97.45% | Lab F |
| 6 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.1 | 30mg | 31.2mg | +4.2% | 98.65% | Lab E |
| 6 Jan 2026 | Telmisartan | 7.1 | 10mg | 11.4mg | +13.7% | 98.40% | Lab E |
| 29 Dec 2025 | 5-amino-1MQ | 5.1 | 50mg | 45.3mg | -9.5% | 99.39% | Lab G |
| 29 Dec 2025 | AHK-CU | 8.6 | 5mg | 5.9mg | +18.7% | 97.69% | Lab B |
| 29 Dec 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 9.7 | 200mg/ml | 222.9mg/ml | +11.5% | 95.03% | Lab C |
| 29 Dec 2025 | Methylene Blue | 7.3 | 25mg | 24.1mg | -3.6% | 99.48% | Lab B |
| 29 Dec 2025 | Methylene Blue | 9.2 | 25mg | 29.8mg | +19.2% | 98.91% | Lab F |
| 29 Dec 2025 | PE 22-28 | 8.7 | 50mg | 46.7mg | -6.7% | 98.16% | Lab A |
| 12 Dec 2025 | Andarine S4 | 6.5 | 25mg | 24.0mg | -4.2% | 97.53% | Lab E |
| 12 Dec 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.0 | 200mg/ml | 188.7mg/ml | -5.6% | 95.20% | Lab G |
| 12 Dec 2025 | SNAP-8 | 6.5 | 5mg | 6.0mg | +19.2% | 97.13% | Lab C |
| 5 Dec 2025 | Methylene Blue | 5.9 | 10mg | 9.5mg | -5.2% | 96.19% | Lab D |
| 5 Dec 2025 | Methylene Blue | 6.3 | 10mg | 8.9mg | -11.3% | 98.21% | Lab D |
| 5 Dec 2025 | Test Undecanoate | 6.0 | 300mg/ml | 292.2mg/ml | -2.6% | 95.27% | Lab E |
| 23 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.7 | 10mg | 11.5mg | +15.1% | 98.66% | Lab A |
| 23 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 6.7 | 100mg | 101.2mg | +1.2% | 98.92% | Lab F |
| 23 Nov 2025 | SNAP-8 | 8.5 | 10mg | 9.5mg | -5.0% | 97.11% | Lab E |
| 17 Nov 2025 | AHK-CU | 7.3 | 30mg | 35.5mg | +18.2% | 99.24% | Lab F |
| 17 Nov 2025 | BMK ethyl glycidate CAS 41232-97-7 | 7.8 | 1g | 1.2g | +19.9% | 98.04% | Lab F |
| 17 Nov 2025 | Dianabol | 6.9 | 20mg | 21.9mg | +9.6% | 95.24% | Lab F |
| 17 Nov 2025 | EPO | 8.2 | 5mg | 4.3mg | -14.4% | 97.47% | Lab A |
| 17 Nov 2025 | HMG | 7.2 | 5mg | 4.3mg | -13.5% | 99.40% | Lab E |
| 17 Nov 2025 | HMG | 7.3 | 10mg | 10.7mg | +7.4% | 96.60% | Lab E |
| 17 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 9.5 | 10mg | 11.6mg | +16.2% | 98.31% | Lab C |
| 14 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.2 | 30mg | 28.3mg | -5.7% | 97.91% | Lab A |
| 14 Nov 2025 | Dianabol | 6.9 | 20mg | 23.1mg | +15.4% | 98.94% | Lab E |
| 14 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 6.3 | 100g | 106.2g | +6.2% | 98.79% | Lab F |
| 14 Nov 2025 | HMG | 9.9 | 15mg | 16.0mg | +6.9% | 98.43% | Lab D |
| 5 Nov 2025 | Livagen | 8.4 | 2mg | 2.2mg | +10.8% | 99.40% | Lab E |
| 5 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 7.3 | 10mg | 12.2mg | +22.3% | 98.76% | Lab C |
| 5 Nov 2025 | SR9009 | 7.3 | 20mg | 21.7mg | +8.7% | 97.90% | Lab D |
| 4 Nov 2025 | DSIP | 9.4 | 10mg | 11.0mg | +10.1% | 97.33% | Lab G |
| 4 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 6.7 | 10mg | 9.1mg | -9.2% | 96.75% | Lab D |
| 4 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 7.1 | 50mg | 50.8mg | +1.7% | 98.93% | Lab A |
| 17 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.0 | 2mg | 1.8mg | -9.6% | 98.38% | Lab C |
| 3 Oct 2025 | Test Undecanoate | 6.9 | 250mg/ml | 286.9mg/ml | +14.8% | 96.12% | Lab B |